Cavenous Involvement in a Paint with Multiple Myeloma
PDF
Cite
Share
Request
Case Report
VOLUME: 71 ISSUE: 3
P: 268 - 270
December 2018

Cavenous Involvement in a Paint with Multiple Myeloma

J Ankara Univ Fac Med 2018;71(3):268-270
1. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi, Nöroloji Anabilim Dalı, Kahramanmaraş, Türkiye
2. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi, Radyoloji Anabilim Dalı, Kahramanmaraş, Türkiye
No information available.
No information available
Received Date: 03.05.2018
Accepted Date: 28.05.2018
Publish Date: 26.03.2019
PDF
Cite
Share
Request

ABSTRACT

Multipl myeloma is a systemic disease with neoplastic proliferation of plasma cells. Cavernous sinus involvement is rare in multipl myeloma. The role of imaging with MRI to exclusion of involvement is great because the cavernous sinus can be evaluated very well by magnetic resonance imaging (MRI). Our case, a seventy seven-year-old female patient, applied to our policlinic with visual disturbance in the left eye. In the neurological examination of the patient; left eye was inside in the primer position, bilateral external view limitation was present marked in the left eye and downward view limitation was present in the left eye. Patient’s brain MRI showed patchy and nodal signals in the frontoparietal lob borderzone area may be compatible with infarct and causing asymmetric enhancement of the left cavernous sinus and expanding soft tissue lesion was detected. The patient was evaluated as multiple myeloma-associated left cavernous sinus involvement and the patient was directed to oncologic treatment center to re-evaluate her oncologic therapy. Since cavernous sinus involvement is rare in multiple myeloma, we found this patient worthy to present.

Keywords:
Myeloma, Cavernous Sinus Involvement, Ophthalmoplegia

References

1
Chen K-Y, Hsu S, Chen M-T, et al. Multipl myeloma with cavernous sinus involvement. Kaohsiung J Med Sci. 2013;29:517-518.
2
Nieuwenhuizen L, Biesma DH. Central nervous system myelomatosis: review of the literature. Eur J Haematol. 2007;80:1-9.
3
Hata N.Y, Katai N, Oshitari T. Ophthalmic manifestations of hematopoietic malignancies. Case Reports in Ophthalmological medicine 2016.
4
Na J.H, Park S. H, Shin S.Y. Multipl myeloma manifesting as a fluctuating sixth nerve palsy. Kaohsiung J Med Sci. 2009;23:232-233.
5
Vande B.I, Stadrik T, Meurs A, et al. Extramedullary plasmacytoma of the cavernous sinus. Leuk Lymhoma. 2002;43:1691-1693.
6
Morkalban C, Martin- Aresti J, Patier JL, et al. Unusual cases in multipl myeloma and a dramatic response in metastatic lung cancer: case 3. intracranial plasmacytoma with cranial nerve neuropathy in multipl myeloma. J Clin Oncol. 2005;23:233-234.
7
Gozzetti A, Cerase A, Tarantino A, et al. Multipl myeloma involving the cavernous sinus: a report of 3 cases and response to bortezomib 2007;5:376-378.
8
Peker S, Abacioglu U, Bayrakli F, et al. Gama knife radiosurgery for cavernous sinus plasmacytoma in patient with breast cancer history. Surg Neurol. 2005;63:174-176.
9
Shpilberg KA, Esses SJ, Fowkes ME, et al. Imaging of extraosseous intracranial and intraspinal multiple myeloma, including central nervous system involvement. Clin Imaging. 2015;39:213-219.
10
Okamoto Y, Minami M, Tohno E, et al. Multifocal peripheral nerve involvement associated with multipl myeloma. Skeletal Radiol. 2007;36:1191-1193.
11
Kyoda K, Nakamura S, Takeshima M, et al. Cavernous sinus syndrome associated with nonsecretory myeloma. Intern Med. 1999;38:988-990.
12
Vande Broek I, Stadnik T, Meurs A, et al. Extramedullary plasmacytoma of the cavernous sinus. Leuk Lymphoma. 2002;43:1691-1693.
13
Fung S, Selva D, Leibovitch I, et al. Ophthalmic manifestations of multiple myeloma. Ophthalmologica. 2005;219:43-48.
14
Patriarca F, Zaja F, Silvestri F, et al. Meningeal and serebral involvement in multipl myeloma patients. Ann Hematol. 2001;80:758-762.
15
Fassas AB, Ward S, Muwalla F, et al. Myeloma of central nervous system: strong association with unfavorable chromosomal abnormalities and other high- risk diseasefeatures. Leuk Lymphoma. 2004;4:291-300.